Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Cardiovasc Dev Dis ; 10(9)2023 Aug 26.
Article in English | MEDLINE | ID: mdl-37754795

ABSTRACT

A considerable number of infective endocarditis (IE) patients require cardiac surgery with an increased risk for postoperative sepsis. Intraoperative hemoadsorption may diminish the risk of postoperative hyperinflammation with potential economic implications for intensive care unit (ICU) occupation. The present study aimed to theoretically investigate the budget impact of a reduced length of ICU stay in IE patients treated with intraoperative hemoadsorption in the German healthcare system. Data on ICU occupation were extrapolated from a retrospective study on IE patients treated with hemoadsorption. An Excel-based budget impact model was developed to simulate the patient course over the ICU stay. A base-case scenario without therapy reimbursement and a scenario with full therapy reimbursement were explored. The annual eligible German IE patient population was derived from official German Diagnostic-Related Group (DRG) volume data. One-way deterministic sensitivity analysis and multivariate analysis were performed to evaluate the uncertainty over the model results. The use of intraoperative hemoadsorption resulted in EUR 2298 being saved per patient in the base-case scenario without therapy reimbursement. The savings increased to EUR 3804 per patient in the case of full device-specific reimbursement. Deterministic and probabilistic sensitivity analyses confirmed the robustness of savings, with a probability of savings of 87% and 99% in the base-case and full reimbursement scenario, respectively. Intraoperative hemoadsorption in IE patients might have relevant economic benefits related to reduced ICU stays, resulting in improved resource use. Further evaluations in larger prospective cohorts are warranted.

2.
HNO ; 69(4): 303-311, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33666682

ABSTRACT

BACKGROUND: One of the main symptoms of severe infection with the new coronavirus­2 (SARS-CoV-2) is hypoxemic respiratory failure because of viral pneumonia with the need for mechanical ventilation. Prolonged mechanical ventilation may require a tracheostomy, but the increased risk for contamination is a matter of considerable debate. OBJECTIVE: Evaluation of safety and effects of surgical tracheostomy on ventilation parameters and outcome in patients with COVID-19. STUDY DESIGN: Retrospective observational study between March 27 and May 18, 2020, in a single-center coronavirus disease-designated ICU at a tertiary care German hospital. PATIENTS: Patients with COVID-19 were treated with open surgical tracheostomy due to severe hypoxemic respiratory failure requiring mechanical ventilation. MEASUREMENTS: Clinical and ventilation data were obtained from medical records in a retrospective manner. RESULTS: A total of 18 patients with confirmed SARS-CoV­2 infection and surgical tracheostomy were analyzed. The age range was 42-87 years. All patients received open tracheostomy between 2-16 days after admission. Ventilation after tracheostomy was less invasive (reduction in PEAK and positive end-expiratory pressure [PEEP]) and lung compliance increased over time after tracheostomy. Also, sedative drugs could be reduced, and patients had a reduced need of norepinephrine to maintain hemodynamic stability. Six of 18 patients died. All surgical staff were equipped with N99-masks and facial shields or with powered air-purifying respirators (PAPR). CONCLUSION: Our data suggest that open surgical tracheostomy can be performed without severe complications in patients with COVID-19. Tracheostomy may reduce invasiveness of mechanical ventilation and the need for sedative drugs and norepinehprine. Recommendations for personal protective equipment (PPE) for surgical staff should be followed when PPE is available to avoid contamination of the personnel.


Subject(s)
COVID-19 , Pneumonia, Viral , Adult , Aged , Aged, 80 and over , Humans , Middle Aged , Retrospective Studies , SARS-CoV-2 , Tracheostomy/adverse effects
3.
Naunyn Schmiedebergs Arch Pharmacol ; 390(5): 519-526, 2017 May.
Article in English | MEDLINE | ID: mdl-28144710

ABSTRACT

Metamizole (dipyrone) is a first-line, non-opioid analgesic used for postoperative pain management. Clinical data and animal experiments indicate a possible vasodilator action of this drug. We investigated the effects of metamizole on human artery and vein tone in an ex vivo model to assess potential contributions to venous pooling. Excess segments of bypass grafts were harvested during coronary artery bypass grafting procedures. Tensions were measured in an organ bath for 120 min after adding metamizole to the preconstricted vessels. Contribution of endothelium was assessed in endothelium-denuded vessels, and indometacin was used to identify cyclooxygenase-mediated effects. Internal mammary arteries (n = 6) constricted after addition of 1, 3, and 10 µM metamizole and remained constricted at the lower doses. Transient constrictions also occurred in saphenous veins (n = 20), but veins relaxed below solvent controls after 20 min at all concentrations. Endothelium removal (n = 12) and cyclooxygenase inhibition (n = 12) suppressed the vasoconstrictor effect but not the vasodilator effect. Metamizole and its metabolites display counteracting effects on blood vessel tone ex vivo. The vasoconstrictor effect is mediated by cyclooxygenase-derived products. The net effect is site-specific, resulting in a selective venous vasodilator action. This may exacerbate unwanted venous pooling during postoperative pain therapy.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Dipyrone/pharmacology , Mammary Arteries/drug effects , Pain, Postoperative/drug therapy , Saphenous Vein/drug effects , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Vasodilation/drug effects , Vasodilator Agents/pharmacology , Aged , Anti-Inflammatory Agents, Non-Steroidal/toxicity , Cyclooxygenase Inhibitors/pharmacology , Dipyrone/toxicity , Dose-Response Relationship, Drug , Female , Humans , In Vitro Techniques , Indomethacin/pharmacology , Male , Middle Aged , Pain, Postoperative/physiopathology , Time Factors , Vasoconstrictor Agents/toxicity , Vasodilator Agents/toxicity
4.
BMC Med Inform Decis Mak ; 9: 25, 2009 May 18.
Article in English | MEDLINE | ID: mdl-19450242

ABSTRACT

BACKGROUND: Revised consensus sepsis definitions have been published in 2003. The present study was performed to compare the prevalence of different stages of sepsis and ICU mortality rates and find out the case mix within the same collective of postoperative/posttraumatic patients applying either the original 1992 ACCP/SCCM or the revised 2003 SCCM/ESICM/ACCP/ATS/SIS sepsis definitions. METHODS: Retrospective observational single-centre study in surgical critically ill patients admitted to an University adult ICU. From 01/2007 to 12/2007, 742 patients were surveyed daily computer-assisted with respect to different stages of sepsis. RESULTS: Within the same patient collective, applying the 2003 definitions instead of the 1992 definitions, prevalence of severe sepsis (61 vs. 56) and septic shock (205 vs. 162) was higher (p < 0.001). In patients with septic shock according to the 2003 definitions, mortality rate of 22% was lower than that of 27%, when the 1992 definitions were used. Risk of death was increased for those patients classified to be in septic shock with any of the definitions (OR 6.5, p = 0.001). Sensitivity to predict deaths was slightly higher with the 2003 definitions (92%) than with the 1992 definitions (88%), and specificity was lower (31% vs. 49%). CONCLUSION: The prevalence and mortality rates of various sepsis severity stages differ if defined by the 1992 or the 2003 definitions. Thus, transferring conclusions drawn from data sets regarding severity of sepsis generated with the 1992 definitions to the same population applying the 2003 definitions may be misleading. The 1992 definitions may under-classify patients with severe sepsis.


Subject(s)
Diagnosis-Related Groups , Postoperative Complications/diagnosis , Sepsis/diagnosis , Shock, Septic/diagnosis , Systemic Inflammatory Response Syndrome/diagnosis , Terminology as Topic , Adolescent , Adult , Aged , Aged, 80 and over , Cause of Death , Child , Child, Preschool , Consensus Development Conferences as Topic , Cross-Sectional Studies , Female , Germany , Hospital Mortality , Humans , Infant , Intensive Care Units/statistics & numerical data , Male , Middle Aged , Multiple Organ Failure/classification , Multiple Organ Failure/diagnosis , Multiple Organ Failure/mortality , Postoperative Complications/classification , Retrospective Studies , Sepsis/classification , Sepsis/mortality , Shock, Septic/classification , Shock, Septic/mortality , Societies, Medical , Systemic Inflammatory Response Syndrome/classification , Systemic Inflammatory Response Syndrome/mortality , United States , Wounds and Injuries/complications , Wounds and Injuries/mortality , Wounds and Injuries/surgery , Young Adult
5.
Intensive Care Med ; 31(12): 1719-22, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16231068

ABSTRACT

OBJECTIVE: To investigate whether the plasma disappearance rate of indocyanine green (ICG) assessed using a commercially available bedside monitor provides an accurate estimation of cumulative biliary ICG excretion in a clinically relevant model of long-term, hyperdynamic porcine endotoxemia. DESIGN AND SETTING: Prospective experimental study in the animal laboratory in a university hospital. SUBJECTS: Fifteen domestic pigs. INTERVENTIONS: Pigs were anesthetized, mechanically ventilated, and instrumented. Intravenous endotoxin was continuously infused over 12 h concomitant with fluid resuscitation. Measurements were performed before and 12 h after the start of endotoxin infusion. MEASUREMENTS AND RESULTS: All animals developed hyperdynamic circulation characterized by a sustained increase in cardiac output. Despite well maintained portal venous and consequently total liver blood flow endotoxemia decreased hepatic lactate uptake, which was accompanied by a significant fall in portal and hepatic venous pH. Both the cumulative bile flow and biliary ICG and bicarbonate excretion measured during 1 h after intravenous bolus of 25 mg ICG fell significantly. By contrast, neither the plasma disappearance rate of ICG nor the rate corrected for liver blood flow exhibited any changes over time. CONCLUSIONS: In hyperdynamic porcine endotoxemia the plasma disappearance rate of ICG failed to accurately substitute for direct short-term measures of biliary ICG excretion. Hence normal values of plasma disappearance rate of ICG should be interpreted with caution in early, acute inflammatory conditions.


Subject(s)
Bile/metabolism , Coloring Agents , Indocyanine Green , Liver Function Tests/methods , Sepsis/diagnosis , Animals , Coloring Agents/pharmacokinetics , Endotoxemia , Hemodynamics , Indocyanine Green/pharmacokinetics , Liver/blood supply , Liver/metabolism , Metabolic Clearance Rate , Point-of-Care Systems , Predictive Value of Tests , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...